In addition, the PR65α and PR65β subunits of PP2A have been identified as tumor suppressors; in fact, their genes are mutated in melanomas and lung and breast cancers for PR65α and in 15% of cell lines derived from the primary lung and colon for PR65β [10]. The gene discussed is PTPA; the disease is breast carcinoma.